We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > catalyst

News List

Catalyst holds firm on $300,000-plus net for Firdapse despite Bernie Sanders’ demands to justify the price fiercepharma
February 24, 2019
Just one week after Vermont Sen. Bernie Sanders sent a scathing letter to Catalyst Pharmaceuticals CEO questioning his plans to charge $375,000 for its rare-disease drug Firdapse, the company said it's sticking to that number.
Catalyst holds firm on $300,000-plus net for Firdapse despite Bernie Sanders’ demands to justify the price fiercepharma
February 24, 2019
Just one week after Vermont Sen. Bernie Sanders sent a scathing letter to Catalyst Pharmaceuticals CEO questioning his plans to charge $375,000 for its rare-disease drug Firdapse, the company said it's sticking to that number.
Catalyst sparks price row in US with $300,000 rare disease drug pharmaphorum
February 13, 2019
The controversy over rising drug prices in the US has been reignited after it emerged that the yearly cost of the life-sustaining rare disease drug Firdapse has been hiked from free to more than $300,000.

Previous page 1 2 Next page